Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Deckers Outdoor Corporation · DECK · FY2027 Q1 · Calendar Q3 2026
Deckers delivered its first-ever $1 billion quarterly revenue in Q1 FY27, growing 5.7% YoY on 13% DTC expansion across HOKA and UGG. Gross margin improved 60 bps to 56.4% through full-price sell-through and disciplined close-out management. Management raised FY27 EPS guidance to $7.35-$7.50 while increasing its tariff-rate assumption from 10% to 12.5%, signaling confidence that brand strength and pricing discipline can absorb cost headwinds. The bullish score moderated to 78 from 85, reflecting analyst caution around margin sustainability and tariff refund timing.
Deckers Outdoor Corporation, operating with its subsidiaries, is a global enterprise dedicated to the creation, promotion, and distribution of footwear, apparel, and accessories. Its product lines serve both casual everyday needs and specialized high-performance activities. The company manages a portfolio of prominent brands: Under the UGG label, it offers premium footwear, clothing, and related items. Teva is known for its range of sandals, shoes, and boots. Sanuk provides comfortable, relaxed casual shoes and sandals. For the athletic segment, particularly ultra-runners and other athletes, Hoka supplies specialized footwear and apparel. Lastly, Koolaburra features fashionable casual footwear, often incorporating plush materials.…
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Jul 24, 2026 |
| Telsey Advisory Group | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 24, 2026 |
| Needham | Buy | Buy | Maintain | Jul 24, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jul 13, 2026 |
| UBS | Buy | Buy | Maintain | May 22, 2026 |
| KGI Securities | Neutral | Outperform | Downgrade | May 22, 2026 |
| Piper Sandler | Neutral | Underweight | Upgrade | May 18, 2026 |
| Wells Fargo | Underweight | Equal Weight | Downgrade | May 8, 2026 |
| Bernstein | Market Perform | Underperform | Upgrade | May 6, 2026 |
| Argus Research | Buy | Hold | Upgrade | Feb 20, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jan 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 24, 2025 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 17, 2025 |
| BWG Global | Positive | Mixed | Upgrade | Oct 14, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 25, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 25, 2025 |
| Keybanc | Overweight | Downgrade | May 23, 2025 | |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| Guggenheim | Neutral | Neutral | Maintain | Jan 31, 2025 |
| BTIG | Neutral | Buy | Downgrade | Oct 22, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Oct 7, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Jul 26, 2024 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 3, 2023 |
| Susquehanna | Positive | Positive | Maintain | Apr 6, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 31, 2020 |
| CFRA | Buy | Buy | Maintain | Jan 31, 2020 |
| Pivotal Research | Buy | Hold | Upgrade | Aug 19, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | May 24, 2019 |
| Bank of America | Buy | Neutral | Upgrade | May 21, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 26, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Oct 26, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Jul 27, 2018 |
| B. Riley FBR | Buy | Buy | Maintain | May 5, 2018 |
| Tigress Financial | Neutral | Buy | Downgrade | Apr 18, 2018 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 31, 2017 |
| Standpoint Research | Hold | Buy | Downgrade | Aug 2, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | May 27, 2016 |
| Brean Capital | Buy | Buy | Maintain | May 27, 2016 |
| BB&T Capital | Underweight | Hold | Downgrade | May 13, 2016 |
| Nomura | Neutral | Neutral | Maintain | May 2, 2016 |
| Sterne Agee CRT | Underperform | Neutral | Downgrade | Feb 5, 2016 |
| Sterne Agee | Underperform | Neutral | Downgrade | Feb 5, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Feb 5, 2016 |
| B. Riley Securities | Neutral | Neutral | Maintain | Feb 5, 2016 |
| Wunderlich | Buy | Buy | Maintain | Jan 30, 2015 |
| Wunderlich Securities | Buy | Buy | Maintain | Jan 29, 2015 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2012 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Oct 26, 2012 |
| ISI Group | Buy | Buy | Maintain | Jul 27, 2012 |
| Lazard | Neutral | Buy | Downgrade | Jul 25, 2012 |
| Longbow Research | Neutral | Buy | Downgrade | Jul 6, 2012 |
| Ladenburg Thalmann | Sell | Buy | Downgrade | Apr 30, 2012 |
Upside is calculated against the persisted previous close $99.69. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Needham | Tom Nikic | $125 | $96.23 | +25.4% | Jul 24, 2026 |
| Stifel Nicolaus | Analyst unavailable | $133 | $96.23 | +33.4% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $115 | $96.23 | +15.4% | Jul 24, 2026 |
| Wells Fargo | Ike Boruchow | $85 | $96.23 | -14.7% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $133 | $96.23 | +33.4% | Jul 24, 2026 |
| Jefferies | Analyst unavailable | $130 | $105.99 | +30.4% | Jul 13, 2026 |
| Argus Research | Analyst unavailable | $128 | $114.35 | +28.4% | May 29, 2026 |
| Stifel Nicolaus | Peter McGoldrick | $144 | $114.31 | +44.4% | May 29, 2026 |
| Barclays | Adrienne Yih | $141 | $106.67 | +41.4% | May 26, 2026 |
| Telsey Advisory | Analyst unavailable | $113 | $103.01 | +13.4% | May 22, 2026 |
| Bernstein | Aneesha Sherman | $105 | $102.86 | +5.3% | May 22, 2026 |
| Truist Financial | Joseph Civello | $125 | $102.62 | +25.4% | May 22, 2026 |
| KGI Securities | Analyst unavailable | $117 | $102.62 | +17.4% | May 22, 2026 |
| Piper Sandler | Analyst unavailable | $100 | $93.56 | +0.3% | May 18, 2026 |
| UBS | Jay Sole | $145 | $93.93 | +45.5% | May 14, 2026 |
| Wells Fargo | Ike Boruchow | $90 | $102.72 | -9.7% | May 8, 2026 |
| Raymond James | Rick Patel | $133 | $107.69 | +33.4% | Apr 23, 2026 |
| Wells Fargo | Ike Boruchow | $115 | $107.81 | +15.4% | Apr 15, 2026 |
| Truist Financial | Analyst unavailable | $132 | $114.52 | +32.4% | Jan 30, 2026 |
| Needham | Analyst unavailable | $138 | $115.15 | +38.4% | Jan 30, 2026 |
| UBS | Analyst unavailable | $161 | $114.87 | +61.5% | Jan 30, 2026 |
| Stifel Nicolaus | Peter McGoldrick | $140 | $99.9 | +40.4% | Jan 30, 2026 |
| Bernstein | Analyst unavailable | $90 | $99.9 | -9.7% | Jan 30, 2026 |
| Goldman Sachs | Analyst unavailable | $92 | $99.9 | -7.7% | Jan 30, 2026 |
| Piper Sandler | Analyst unavailable | $95 | $99.9 | -4.7% | Jan 30, 2026 |
| Wells Fargo | Ike Boruchow | $110 | $99.9 | +10.3% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $143 | $99.9 | +43.4% | Jan 30, 2026 |
| Evercore ISI | Jesalyn Wong | $108 | $99.9 | +8.3% | Jan 30, 2026 |
| KGI Securities | Analyst unavailable | $129 | $99.9 | +29.4% | Jan 30, 2026 |
| Truist Financial | Joseph Civello | $115 | $100.46 | +15.4% | Jan 14, 2026 |
| Jefferies | Analyst unavailable | $102 | $101.71 | +2.3% | Jan 14, 2026 |
| Piper Sandler | Anna Andreeva | $85 | $107.46 | -14.7% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $113 | $89.4 | +13.4% | Oct 27, 2025 |
| Telsey Advisory | Dana Telsey | $105 | $89.8 | +5.3% | Oct 24, 2025 |
| Truist Financial | Analyst unavailable | $105 | $87.94 | +5.3% | Oct 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $117 | $102.54 | +17.4% | Oct 24, 2025 |
| Raymond James | Rick Patel | $115 | $87.94 | +15.4% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $125 | $102.54 | +25.4% | Oct 24, 2025 |
| Needham | Tom Nikic | $113 | $87.94 | +13.4% | Oct 24, 2025 |
| Jefferies | Analyst unavailable | $107 | $103.7 | +7.3% | Oct 23, 2025 |
| Stifel Nicolaus | Peter McGoldrick | $127 | $100.19 | +27.4% | Oct 21, 2025 |
| UBS | Analyst unavailable | $157 | $97.98 | +57.5% | Oct 8, 2025 |
| Bernstein | Analyst unavailable | $100 | $118.68 | +0.3% | Sep 17, 2025 |
| Evercore ISI | Jesalyn Wong | $115 | $116.85 | +15.4% | Jul 25, 2025 |
| Wells Fargo | Ike Boruchow | $100 | $101.1 | +0.3% | May 23, 2025 |
| UBS | Jay Sole | $169 | $101.05 | +69.5% | May 23, 2025 |
| Needham | Tom Nikic | $150 | $123.36 | +50.5% | May 21, 2025 |
| UBS | Jay Sole | $267 | $207.5 | +167.8% | Jan 10, 2025 |
| Needham | Tom Nikic | $226 | $202.06 | +126.7% | Dec 5, 2024 |
| Piper Sandler | Anna Andreeva | $166 | $161.16 | +66.5% | Oct 17, 2024 |
| Evercore ISI | Jesalyn Wong | $185 | $161.85 | +85.6% | Oct 15, 2024 |
| Bank of America Securities | Chris Nardone | $170 | $157.54 | +70.5% | Sep 18, 2024 |
| Williams Trading | Sam Poser | $189 | $153.25 | +89.6% | Sep 17, 2024 |
| Piper Sandler | Anna Andreeva | $167 | $159.47 | +67.5% | Aug 22, 2024 |
| Telsey Advisory | Dana Telsey | $183.7 | $152.22 | +84.3% | Jul 26, 2024 |
| UBS | Jay Sole | $225.45 | $140.53 | +126.2% | Jul 26, 2024 |
| Barclays | Adrienne Yih | $182.03 | $140.53 | +82.6% | Jul 26, 2024 |
| Seaport Global | Mitch Kummetz | $187.88 | $164.33 | +88.5% | Jun 25, 2024 |
| BTIG | Janine Stichter | $200.4 | $163.34 | +101.0% | Jun 25, 2024 |
| Truist Financial | Joseph Civello | $200.4 | $172.49 | +101.0% | May 28, 2024 |
| Wedbush | Tom Nikic | $172.01 | $151.08 | +72.5% | May 24, 2024 |
| Robert W. Baird | Jonathan Komp | $175.35 | $171.14 | +75.9% | May 24, 2024 |
| Wells Fargo | Ike Boruchow | $167 | $151.08 | +67.5% | May 24, 2024 |
| Seaport Global | Mitch Kummetz | $175.35 | $151.08 | +75.9% | May 24, 2024 |
| BTIG | Janine Stichter | $187.04 | $151.08 | +87.6% | May 24, 2024 |
| Barclays | Adrienne Yih | $181.86 | $151.08 | +82.4% | May 24, 2024 |
| Evercore ISI | Jesalyn Wong | $185.37 | $151.08 | +85.9% | May 24, 2024 |
| UBS | Jay Sole | $211.26 | $151.08 | +111.9% | May 24, 2024 |
| KeyBanc | Ashley Owens | $169.51 | $170.96 | +70.0% | May 24, 2024 |
| Telsey Advisory | Dana Telsey | $164.5 | $151.06 | +65.0% | May 20, 2024 |
| BTIG | Janine Stichter | $170.34 | $148.39 | +70.9% | May 20, 2024 |
| Williams Trading | Sam Poser | $168.67 | $147.37 | +69.2% | May 14, 2024 |
| Truist Financial | Joseph Civello | $144.29 | $134.74 | +44.7% | Apr 10, 2024 |
| Piper Sandler | Abbie Zvejnieks | $145.29 | $148.44 | +45.7% | Apr 9, 2024 |
| Barclays | Adrienne Yih | $185.37 | $157.19 | +85.9% | Apr 1, 2024 |
| BTIG | Janine Stichter | $515 | $416.22 | +416.6% | Feb 6, 2023 |
| Cowen & Co. | Analyst unavailable | $480 | $421.11 | +381.5% | Feb 3, 2023 |
| Telsey Advisory | Analyst unavailable | $485 | $421.33 | +386.5% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $360 | $395.08 | +261.1% | Jan 6, 2023 |
| Piper Sandler | Analyst unavailable | $470 | $389.94 | +371.5% | Jan 5, 2023 |
| Stifel Nicolaus | Jim Duffy | $416 | $346.24 | +317.3% | Nov 7, 2022 |
| Wedbush | Tom Nikic | $65.13 | $61.23 | -34.7% | Oct 4, 2021 |
| UBS | Jay Sole | $540 | $430.17 | +441.7% | Aug 12, 2021 |
| Bank of America Securities | Rafe Jadrosich | $425 | $335.76 | +326.3% | May 21, 2021 |
Track every rating change on DECK the moment it posts. Free to start.
Start freeFollow DECK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeFrom Q4 FY26 to Q1 FY27: Revenue crossed $1B for the first time, up 5.7% YoY. EPS of $0.94 beat estimates by 6.8%. DTC growth decelerated from 18% to 13%. Gross margin expanded 60 bps to 56.4%. FY27 EPS guidance was raised from $7.30-$7.45 to $7.35-$7.50 while revenue guidance was reaffirmed at $5.86-$5.91B. The tariff-rate assumption increased from 10% to 12.5%, with the company now pursuing IEEPA-related tariff refunds. Share repurchases totaled $338M in the quarter. The bullish score declined from 85 to 78.
FY27 revenue guidance reaffirmed at $5.86-$5.91B. EPS guidance raised from $7.30-$7.45 to $7.35-$7.50, reflecting higher gross-margin assumptions. Tariff-rate assumption increased from 10% to 12.5%. The company is pursuing IEEPA-related tariff refunds, which could provide a future tailwind if recovered. Capex guidance was not addressed this quarter; the prior outlook was $145-$155M.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.